| Naziv: | Unlocking the power of affibody conjugated radioactive metallopharmaceuticals for targeted cancer diagnosis and therapy |
Autori: | Murugan, Dhanashree; Thirumalaiswamy, Harashkumar Vasanthakumari; Murugesan, Vasanth; Venkatesan, Janarthanan; Balachandran, Unnikrishnan; Lakshminarayanan, Kalaiarasu; Satpati, Drishty; Nikolic, Stefan   ; Rangasamy, Loganathan |
Godina: | 2025 |
Publikacija: | PHARMACOLOGY & THERAPEUTICS |
ISSN: | 0163-7258 Pharmacology and Therapeutics Pretraži identifikator |
Tip rezultata: | Naučna kritika i polemika |
Kolacija: | vol. 272 str. 108863-108863 |
DOI: | 10.1016/j.pharmthera.2025.108863 |
WoS-ID: | 001506517700001 |
Scopus-ID: | 2-s2.0-105007067852 |
URI: | https://enauka.gov.rs/handle/123456789/985752
https://cherry.chem.bg.ac.rs/handle/123456789/7111
https://cherry.chem.bg.ac.rs/handle/123456789/7110 |
Projekat: | Department of Bio-technology, New Delhi [BT/RLF/Re-entry/44/2018]
Science and Engineering Research Board (SERB), New Delhi [CRG/2020/001213]
Board of Research in Nuclear Sciences (BRNS) [54/14/03/2022-BRNS/10207]
Indian Council of Medical Research (ICMR) [Discovery/IIRP/SG-2387/2023]
VIT SEED GRANT
Vellore Institute of Technology for Faculty Startup Venture (FSV) 2023
Ministry of Education, Science, and Technological Development of the Republic of Serbia [451-03-47/2023-01/200288]
Vellore Institute of Technology for Student Startup Venture (SSV) 2022
Vellore Institute of Technology for Student Startup Venture (SSV) 2023 |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) |
M-kategorija: | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |